empyema; outcome; propensity analysis; video-assisted thoracoscopic surgery Background/Purpose: Acute thoracic empyema is a common clinical problem worldwide, resulting in substantial morbidity and mortality. The objective of this study was to report its clinical characteristics and to evaluate whether thoracoscopic surgery is associated with a lower rate of in-hospital mortality compared with nonoperative drainage. Methods: Between 2001 and 2010, we retrospectively reviewed the clinical characteristics, bacteriological studies, and treatment outcomes of 602 patients with acute thoracic empyema. Thoracoscopic surgery was performed in 417 (69.2%) patients, while the remaining patients underwent nonoperative drainage. After treatment, 77 patients (12.8%) died in the hospital. A propensity score-based process, matched on potential risk factors for in-hospital mortality, was performed to select patients with equalized potential prognostic factors in the thoracoscopy and nonoperative groups. The log-rank test was used to compare the survival time with discharge between the two matched groups.
Introduction
Acute thoracic empyema is an increasingly serious problem worldwide. Approximately 60,000 patients develop thoracic empyema in the United States every year, resulting in significant morbidity and mortality. 1 The mortality rate from pleural infection is between 10% and 20%; drainage through a chest tube and administration of antibiotics fail in approximately one-third of patients, requiring subsequent surgical drainage. 2e4 In 1962, the American Thoracic Society 5 described the three phases of empyema as exudative (Stage I), fibrinopurulent (Stage II), and organizing (Stage III). Although the optimal therapeutic approach for empyema remains undetermined, surgery has been shown to be an effective treatment option, especially in multiloculated fibrinopurulent empyema. By contrast, the risks of surgery need to be balanced against the expected benefits. Empyema management traditionally has been empirical, but recent data favor establishing more specific management guidelines. 2e4,6e12 Since its introduction, video-assisted thoracoscopic surgery (VATS) has become an attractive modality for treating complicated empyema because of its minimal invasiveness and satisfactory efficacy. 2,4,7e12 Although mounting clinical evidence shows that VATS is beneficial for treatment of thoracic empyema, selection bias exists because surgeons tend to choose patients in better condition to obtain satisfactory outcomes.
2,4,6e12 Prospective randomized controlled trials or propensity analysis studies can correct this bias. However, due to the heterogeneousness of patients with different backgrounds constituting the group and with most of them presenting with emergency conditions, it is difficult to conduct a randomized controlled trial. In this study, we used our 10-year experience in managing a large population of acute thoracic empyema patients (Stage II), focusing on the analysis of risk factors, and examining the therapeutic effect of thoracoscopic surgery by propensity analysis, and compared the results with nonoperative drainage on an in-hospital mortality and survival time to discharge basis.
Materials and methods

Patient demographic and clinical features
The medical records of all patients with acute thoracic empyema at the National Taiwan University Hospital during the period from January 2001 to June 2010 were reviewed retrospectively. The Research Ethics Committee of the National Taiwan University Hospital approved this study and waived the requirement for informed consent due to its retrospective nature (approval number: 201203037RIC).
The diagnosis of thoracic empyema was made if a patient had at least one of the following conditions: the presence of purulent material in the pleural space, positive results for loculated pleural fluid culture or Gram stain for microorganisms, and biochemical evidence suggestive of empyema. 13 Exclusion criteria were empyema caused by esophageal rupture, mediastinitis, tuberculosis, fungal infection, postoperative empyema, and pediatric empyema (age < 20 years). Pediatric empyema patients were excluded because the subgroup is a distinct entity, which usually has better outcomes than do adult groups. 12 In addition, chronic empyema patients (Stage III) with or without bronchopleural fistula were excluded. The definition of chronic empyema is the final phase of empyema in which fibroblasts proliferate on the visceral and pleural surfaces, producing a thick inelastic pleural peel. Information collected included demographic features, clinical characteristics, microbiologic and laboratory data, radiographic studies, hospital course, intervention modality, and treatment outcomes.
The algorithm for patient enrollment is shown in Fig. 1 . Based on the selection criteria, 602 patients were included in the study. The characteristics and demographics of the patients with thoracic empyema are listed in Table 1 . The mean age was 58.8 years and 471 patients were male (78.2%). Most patients (499/602; 82.9%) had chronic underlying diseases or associated medical conditions, and the main cause was parapneumonic effusion (84.4%).
Bacteriologic results from samples obtained from the empyema specimens or blood showed that 261 patients (43.4%) had positive cultures. Polymicrobial infections occurred in 43 patients (7.1%) and one-pathogen infections occurred in 218 patients (36.2%). The most common pathogen was Klebsiella pneumoniae (20.7%; found in 67 patients), which was followed by methicillin-resistant Staphylococcus aureus (MRSA; 15.1%) in 49 patients (Table  2) . When the etiology of empyema was stratified by the pathogen isolated, we found that K. pneumoniae was the most common pathogen in patients with empyema caused by parapneumonic effusion, while MRSA was most common in patients with empyema due to other causes ( Table 2) .
Management
All the patients received empiric broad-spectrum intravenous antibiotics as soon as the diagnosis of thoracic empyema was suspected. Once the causative pathogen was cultured and identified, the antibiotics were adjusted according to the antimicrobial sensitivity testing results. Sonography-guided thoracentesis was performed on all patients and the aspirates were sent for laboratory examination. Chest computed tomography was performed to evaluate the extent of the empyema and the severity of pulmonary parenchymal lesions. Patients who had fibropurulent (Stage II) empyema were included in our study. The medical team, including physicians and surgeons, selected nonoperative drainage (repeated thoracentesis or tube thoracostomy) or/and VATS as the methods of treatment.
VATS procedures
None of the patients underwent open thoracotomy as the initial treatment. The patients who were treated with VATS received general anesthesia using double-lumen endotracheal tubes for selective one-lung ventilation. The procedure was performed using a three-port access method. 14 Based on preoperative sonography and computed tomography, suitable intercostal sites were selected for port placement. Fluid, loculations, and septa were removed under endoscopic vision. Adherent peel was carefully removed from visceral and parietal pleural surface and the lung was freed circumferentially from the apex to the diaphragm. Complete decortication of the visceral pleura and the fissures was performed using an endoscopic dissecting device and a peanut dissector, as in open decortication. At the end of the procedure, one or two chest tubes were inserted. The abscess and necrotic tissue from the empyema collection were sent for bacterial cultures and pathological examination. During the postoperative period, a chest plain film was arranged to see whether satisfactory 
Statistical analyses
The primary outcome assessed in this study was in-hospital mortality. Categorical variables were compared using c 2 and Fisher exact tests, and continuous variables were compared using the Student t test. Univariate analyses were performed to assess the associations between each risk factor and inhospital mortality. Variables that had a p < 0.1 in the univariate analyses were subjected to multivariate analysis using a stepwise binary logistic regression. Odds ratios (ORs) and 95% confidence intervals were calculated to determine significance by multivariate analysis. A p value < 0.05 was taken to be significant. Statistical analyses were performed using SPSS version 18 (SPSS Inc., Chicago, IL, USA), and all statistical tests were two sided.
Propensity score-matching methods
Propensity score matching is a method used to balance observed covariates in the two treatment groups. In this study, the propensity score was the conditional probability of undergoing thoracoscopic surgery, as a binary dependent variable, under a set of measurements. Age, sex, parapneumonic effusion, hypertension, diabetes mellitus, coronary arterial disease, malignancy, old stroke, chronic lung disease, chronic renal insufficiency, liver cirrhosis, positive bacterial cultures, and polymicrobial infection were input into a nonparsimonious multivariable logistic regression model to predict the effect of thoracoscopy. The predicted probability derived from the logistic equation was used as the propensity score for each individual. The 602 patients were pooled and sorted according to their propensity score in ascending order. The selection process began from the first two cases with the lowest propensity score. If one underwent thoracoscopy and the other underwent nonoperative management, both were selected as a matched pair. If this was not the case, then four cases were included. In the same way, thoracoscopic and nonoperative cases were matched by their propensity score in 1:1, 2:2, 3:3, or 4:4 blocks. A patient who did not have a suitable match within the acceptable rank range was excluded from further analysis, and the matching process moved down the sort list until all possible matched pairs were included. 15 The selected patients formed well-matched 1:1 pairs in both groups (thoracoscopic surgery vs. nonoperative drainage). KaplaneMeier curves, with follow up until hospital discharge, were plotted to show the survival trend.
The log-rank test was used to compare the differences between the two matched groups. The survival time was defined as the duration from admission to death in the mortality cases, and in the survivors, as the duration from admission to discharge. A logistic regression model was used for the propensity score calculation using SPSS release 18 (SPSS Inc.). Propensity scores in both the thoracoscopic surgery and nonoperative drainage groups were used to draw box plots.
Results
Treatments and outcomes
Of the 602 patients, 417 (69.2%) underwent thoracoscopic surgery for debridement and drainage of the empyema. The remaining 185 patients underwent thoracentesis and/or tube thoracostomy (nonoperative drainage). After treatment, 525 patients survived to discharge, while the remaining 77 patients (12.8%) succumbed in the hospital. In the thoracoscopic group, the conversion to thoracotomy was noted in eight patients (1.9%)ddue to bleeding in five patients and due to extensive and severe adhesion in three patientsdand repeated VATS were noted in 10 patients (2.4%)dsix patients required repeated VATS due to recurrent empyema and it was due to bleeding in the remaining four patients. The median OR time is 116 minutes (range: 50e178 minutes). Regarding postoperative course, most patients were admitted to intensive care unit with intubation (411/417; 98.6%). They were extubated and transferred to the general ward once their condition stabilized. The postoperative period was 19.0 AE 18.3 days and the chest-tube drainage period was 16.8 AE 15.9 days. The mean hospital stay of the total population was 30.5 AE 27.4 days ( Table 1) .
To identify the factors associated with in-hospital mortality, the clinical characteristics, bacteriology, and management between survivors and nonsurvivors were summarized and compared by univariate analysis. We found that age, right-sided empyema, history of malignancy, coronary arterial disease, chronic lung disease, chronic renal insufficiency, liver cirrhosis, empyema due to hepatic hydrothorax, positive bacterial cultures, polymicrobial infection, and MRSA infection were associated with a significantly higher rate of in-hospital mortality. By contrast, patients with the etiology of parapneumonic effusion and those who underwent thoracoscopy had a significantly lower rate of in-hospital mortality. Multivariate logistic regression analysis showed that age, malignancy, chronic lung disease, chronic renal insufficiency, liver cirrhosis, polymicrobial infection, and positive bacterial cultures were risk factors for in-hospital mortality, while VATS significantly favored survival (Table 3) .
Thoracoscopic surgery versus nonoperative drainage
To analyze the role of thoracoscopic surgery in empyema, patients were grouped according to whether they received thoracoscopic surgery or nonoperative drainage. There were 417 (69.2%) patients in the thoracoscopy group and 185 (30.8%) in the nonoperative group. Patients in the thoracoscopy group were younger, had a lower percentage of malignancies and liver cirrhosis, and a lower rate of inhospital mortality (7.5% vs. 24.9%, p Z 0.001). The survival time to discharge in survivors between the two groups was comparable (Table 4) . Using the propensity score-matching method, 148 patients from the thoracoscopy group and 148 patients from the nonoperative group were selected for further analysis. Baseline characteristics, including age, sex, etiology, and comorbidity, were all comparable in the two groups after propensity score matching. The in-hospital mortality difference between the two groups was significant (p Z 0.014; Table 5 ). The KaplaneMeier survival analysis revealed a higher survival rate to discharge, favoring thoracoscopic over nonoperative treatment (logrank test p < 0.001; Fig. 2 ).
Discussion
The treatment of thoracic empyema in the fibropurulent stage focuses on infection control in the pleural cavity and prevention of late pulmonary restriction due to encasement of the lungs. Antibiotics, pigtail drain insertion, and tube thoracostomy still play major roles in the initial management of empyema. However, by these methods, it is reported that 36e65% of the patients are not cured, even with a prolonged hospital stay. 2,3 VATS, a procedure that is more effective than tube drainage, is an attractive alternative for treating empyema. Our results showed that age, malignancy, chronic lung disease, chronic renal insufficiency, liver cirrhosis, polymicrobial infection, and positive bacterial culture were significant risk factors for mortality, while VATS was significantly favorable to survival compared with nonoperative drainage.
In our study, most of the empyema patients (499/602, 82.9%) had additional chronic underlying diseases or associated medical conditions. For patients with coexisting cancer, immunity was weakened by the malignancy, which was associated with a high mortality rate. Moreover, old age, chronic lung disease, chronic renal insufficiency, and liver cirrhosis make patients more vulnerable, and thus the management of thoracic empyema becomes complicated and difficult.
15e18 A possible explanation for the more difficult course is that these patients' immunity was severely compromised so that the retained pus resulted in sepsis and, finally, multiple organ failure. As a result, the overall mean hospital stay was long (30.5 days) and the mortality rate was high. 2e4,7,8,11,19 As for the causes of mortality, septic shock was the most common, comprising 6.7% (28/417) and 20.5% (38/185) in the thoracoscopic surgery group and the nonoperative group, respectively. Compared with a previous report in our institute a decade earlier, we found that the mortality rate was comparable (12.8% currently vs. 13.5% previously). 20 Our study showed that K. pneumoniae was still the most common pathogen, as with many other empyema patients in Taiwan. 20, 21 When taking the etiology of empyema into consideration, K. pneumoniae was the main causative pathogen in parapneumonic effusions, while MRSA was more common in other causes, especially in patients with liver cirrhosis. 15 Compared with the pediatric empyema studies conducted recently in our institute where the most common pathogen was Streptococcus pneumoniae in children, the adult patients encountered more complicated courses with higher mortality rates. 12 Polymicrobial infection and positive bacterial cultures were independent risk factors for in-hospital mortality in our study. Bacterial overgrowth, despite antibiotic therapy and drainage, indicates potentially greater bacterial toxicity or poor host immunity, resulting in poor outcomes. 22, 23 One of the most challenging decisions in treating patients with empyema is to select the optimal intervention to evacuate the pus and obliterate the pleural space. The evolutionary stages of pleural empyema are not clearly defined, but rather represent a continuous spectrum of events. 9 Thoracoscopy provides minimally invasive access to the pleural space at the initial time and is effective in evacuating viscous pleural fluid, lysing adhesions to promote the drainage of locules, and placing chest tubes in dependent regions of empyema under direct visualization. 24, 25 According to our experience, thoracoscopy drains most of the loculated empyema with minimal trauma to the pleural cavity, which is especially beneficial in patients with complications. Less invasiveness and less surgical trauma with thoracoscopy also reduce impairment of patient immunity and inflammatory and cytokine responses.
26e28 Although repeated surgery is sometimes required for inadequate drainage or bleeding, it has the advantage of minimal invasiveness. Therefore, we think that thoracoscopy is justified in selected patients after proper preoperative management.
Although operation with thoracoscopic surgery is an attractive tool for fibropurulent empyema, some patients were too sick to be operated due to conditions such as septic shock or multiple organ failure. There are also patients with borderline general condition who may receive thoracoscopic surgery or nonoperative drainage, depending on the decision made by the attending physicians and surgeons. Borderline operable patients are defined as patients who are with clinically moderate condition, that is, not too sick to have surgery nor too well to neglect surgery. Through propensity score matching, these borderline operative patients were selected and analyzed. We found that thoracoscopic surgery is associated with a lower rate of in-hospital mortality compared with nonoperative drainage. Therefore, we encourage surgeons to perform thoracoscopic surgery whenever possible in borderline operable empyema patients.
Study limitations
This study is limited due to its retrospective nature. It could be argued that the surgeons tended to choose patients with better general conditions to obtain better outcomes. Although the multivariate analysis and propensity scorematching methods showed that VATS was an independent factor associated with better survival, some residual bias could still remain. Another limitation is that the treatment policy was not standardized among physicians and surgeons, especially for the timing for thoracoscopic intervention. We believe that a prospective randomized study with precise definitions of variables and standardized treatment protocols would be helpful in validating our results.
Conclusion
Thoracic empyema represents a clinical challenge with a high in-hospital mortality rate due to significant comorbidity. Risk factors associated with mortality are age, coexisting underlying diseases, and polymicrobial and positive bacterial cultures. Our results also suggested that thoracoscopic surgery is feasible and might provide better chances for survival in borderline operable patients.
